Drug intelligence / Profile preview

neomycin sulfate + polymyxin B sulfate + gramicidin

Development stage
Approved
Lead developer
Bausch + Lomb
Modality
Peptides, Small Molecules
Administration
Ophthalmic
01

Overview

Neomycin sulfate + polymyxin B sulfate + gramicidin is a combination antibiotic ophthalmic solution used to treat superficial bacterial infections of the external eye and its adnexa. The three antibiotics provide broad-spectrum antibacterial coverage by targeting both gram-positive and gram-negative organisms. - **Neomycin** is an aminoglycoside antibiotic that inhibits protein synthesis by binding to ribosomal RNA and causing misreading of the bacterial genetic code. - **Polymyxin B** is a polypeptide antibiotic that disrupts the outer cell membrane of gram-negative bacteria by interacting with membrane phospholipids, increasing permeability and leading to cell death. - **Gramicidin** is a peptide antibiotic active mainly against gram-positive bacteria; it increases membrane permeability to inorganic cations by forming channels in the lipid bilayer. This combination is primarily indicated for conjunctivitis (pink eye), keratitis, keratoconjunctivitis, blepharitis, and blepharoconjunctivitis caused by susceptible bacteria[1][3][4][5]. It may not be effective against all pathogens due to possible resistance.

Brand names
Neosporin OphthalmicNeocidinAK-SporeOcu-Spore-GPolymycinNeocin PGNeoptic
Other names
neomycin/polymyxin B/gramicidin ophthalmic solution
02

Targets

16S rRNA (16S ribosomal RNA)LPS (Lipopolysaccharide)

Beyond the preview

Go deeper on neomycin sulfate + polymyxin B sulfate + gramicidin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin sulfate + polymyxin B sulfate + gramicidin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call